SCHEMBL4302173

SCHEMBL4302173

O=S(=O)(O)C(F)(F)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 6/20 0.47
ALDH1A1 P00352 3/20 0.46
CYP3A4 P08684 1/20 0.46
MAPK1 P28482 1/20 0.46
CA1 P00915 4/20 0.46
CA2 P00918 4/20 0.46
CA12 O43570 3/20 0.46
CA3 P07451 3/20 0.46
CA4 P22748 3/20 0.46
CA6 P23280 3/20 0.46
CA5A P35218 3/20 0.46
CA7 P43166 3/20 0.46
CA9 Q16790 3/20 0.46
CA13 Q8N1Q1 3/20 0.46
CA14 Q9ULX7 3/20 0.46
CA5B Q9Y2D0 3/20 0.46
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13950431 0.79 ALDH1A1 (0.50) CNR2ALDH1A1CYP3A4MAPK1CA1
SCHEMBL1828426 0.79 ALDH1A1 (0.54) CNR2ALDH1A1CYP3A4MAPK1CA1
SCHEMBL20572271 0.77 ALDH1A1 (0.52) CNR2ALDH1A1CYP3A4MAPK1CA1
SCHEMBL8941561 0.75 ALDH1A1 (0.50) CNR2ALDH1A1CYP3A4MAPK1CA1
SCHEMBL10083746 0.74 ALDH1A1 (0.61) CNR2ALDH1A1CYP3A4MAPK1CA1
SCHEMBL9489816 0.73 ALDH1A1 (0.48) CNR2ALDH1A1CYP3A4MAPK1CA1
SCHEMBL750671 0.72 ALDH1A1 (0.56) CNR2ALDH1A1CYP3A4MAPK1CA1
SCHEMBL753655 0.72 ALDH1A1 (0.56) CNR2ALDH1A1CYP3A4MAPK1CA1
SCHEMBL2323918 0.72 ALDH1A1 (0.56) CNR2ALDH1A1CYP3A4MAPK1CA1
SCHEMBL10146076 0.71 ALDH1A1 (0.50) CNR2ALDH1A1CYP3A4MAPK1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7482302-B2 triethylammonium (4-chlorophenylsulfonyl)difluoromethanesulfonate used for acid catalysts, ion exchange membranes DAIKIN INDUSTRIES, LTD. (JP) 2009-01-27 US disclosed
US-20060252961-A1 triethylammonium (4-chlorophenylsulfonyl)difluoromethanesulfonate used for acid catalysts, ion exchange membranes DAIKIN INDUSTRIES, LTD. (JP) 2006-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252961-A1 triethylammonium (4-chlorophenylsulfonyl)difluoromethanesulfonate used for acid catalysts, ion exchange membranes SLC26A3, SLC7A1, SLC9A2 CNR2 765/4885ALDH1A1 1528/4885CYP3A4 2718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.